gsk stock forecast

All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2019 and/or its affiliates. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: You have already added five stocks to your watchlist. GlaxoSmithKline has a P/B Ratio of 4.10. Your current $100 investment may be up to $108.55 in 2026. There is not enough analysis data for GlaxoSmithKline. Get Our PREMIUM Forecast Now, from ONLY $6.69! Factset: FactSet Research Systems Inc.2019. View all of GSK's competitors. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Top institutional investors include Douglas Lane & Associates LLC (0.05%), Galibier Capital Management Ltd. (0.02%), Jacobs & Co. CA (0.01%), Holloway Wealth Management LLC (0.00%), Signature Wealth Management Group (0.00%) and Old Port Advisors (0.00%). Given the current horizontal trend, you can expect GlaxoSmithKline PLC stock with a 90% probability to be traded between $33.98 and $39.74 at the end of this 3-month period. View insider buying and selling activity for GlaxoSmithKline or or view top insider-buying stocks. Some companies that are related to GlaxoSmithKline include Roche (RHHBY), Novartis (NVS), Merck & Co., Inc. (MRK), Pfizer (PFE), Abbott Laboratories (ABT), AbbVie (ABBV), Eli Lilly and (LLY), Novo Nordisk A/S (NVO), Bristol-Myers Squibb (BMY), AstraZeneca (AZN), Sanofi (SNY), CSL (CSLLY), Zoetis (ZTS), Vertex Pharmaceuticals (VRTX) and Bayer Aktiengesellschaft (BAYRY). Only 10.00% of the stock of GlaxoSmithKline is held by insiders. GlaxoSmithKline PLC is a global healthcare company. GSK Stock Summary. Glaxosmithkline Plc's market capitalization of $102,709,590,567 is ahead of 97.8% of US-listed equities. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. The Company makes a range of prescription medicines and vaccines … GlaxoSmithKline has only been increasing its dividend for 1 years. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. That leaves the stock trading on just 12 times forecast earnings, with a dividend yield of 5.8%. GlaxoSmithKline pays an annual dividend of $2.04 per share and currently has a dividend yield of 5.30%. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 35.43. Wall Street analysts have given GlaxoSmithKline a "Hold" rating, but there may be better short-term opportunities in the market. All rights reserved. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. The P/E ratio of GlaxoSmithKline is 11.86, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 23.54. MarketBeat thinks these five stocks may be even better buys.View MarketBeat's top stock picks here. According to 6 analysts, the average rating for GSK stock is "Buy." We don’t hear much about the patent cliff anymore, but it’s still a real … However, solely looking at the historical price movement is usually misleading. During the day the stock fluctuated 0.76% from a day low at $37.56 to a day high of $37.84. The firm has a market capitalization of $96.65 billion, a price-to-earnings ratio of 11.82, a price-to-earnings-growth ratio of 2.93 and a beta of 0.67. All rights reserved. 13 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for GlaxoSmithKline in the last year. Price Target Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 1802.630 GBX. ), GlaxoSmithKline has received 1,115 “underperform” votes. It pays a dividend yield of 5.30%, putting its dividend yield in the top 25% of dividend-paying stocks. View insider buying and selling activity for GlaxoSmithKline or view top insider-selling stocks. This price target is based on 12 analysts offering 12 month price targets for GlaxoSmithKline in the last 3 months. GSK Stock Analysis Overview . GLAXOSMITHKLINE PLC : Forcasts, revenue, earnings, analysts expectations, ratios for GLAXOSMITHKLINE PLC Stock | GSK | GB0009252882 Identify stocks that meet your criteria using seven unique stock screeners. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Please log in to your account or sign up in order to add this asset to your watchlist. GlaxoSmithKline is scheduled to release its next quarterly earnings announcement on Wednesday, February 3rd 2021. The Company focuses on its research across six areas: Respiratory diseases, human immunodeficiency v irus (HIV)/infectious diseases, Vaccines, Immuno-inflammation, Oncology and Rare diseases. See GlaxoSmithKline PLC (GSK) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. View which stocks have been most impacted by COVID-19. View our full suite of financial calendars and market data tables, all for free. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). View analyst ratings for GlaxoSmithKline or view MarketBeat's top 5 stock picks. The Glaxosmithkline plc - ADR stock forecast is 70.847354 USD for 2022 January 16, Sunday; and 267.671 USD for 2026 January 16, Friday with technical analysis. To see all exchange delays and terms of use please see disclaimer. This suggests a possible upside of … Get daily stock ideas top-performing Wall Street analysts. GlaxoSmithKline Plc is a healthcare company, which engages in the research, development, and manufacture of pharmaceutical medicines, vaccines, and … The price has been going up and down for this period, and there has been a 1.89% gain for the last 2 weeks. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Vote “Outperform” if you believe GSK will outperform the S&P 500 over the long term. Based on our forecasts, a long-term increase is expected, the "GSK" stock price prognosis for 2025-12-23 is 39.945 USD. This indicates that GlaxoSmithKline will be able to sustain or increase its dividend. View GlaxoSmithKline's dividend history. 19 brokers have issued 1 year price objectives for GlaxoSmithKline plc (GSK.L)'s shares. 150,004 shares of the stock were exchanged, compared to its average … All times are ET. GLAXOSMITHKLINE PLC earnings per share revisions and analysts forecast | London Stock Exchange: GSK | London Stock Exchange A hold rating indicates that analysts believe investors should maintain any existing positions they have in GSK, but not buy additional shares or sell existing shares. GSK stock was acquired by a variety of institutional investors in the last quarter, including Galibier Capital Management Ltd., Douglas Lane & Associates LLC, Gilman Hill Asset Management LLC, Jacobs & Co. CA, SevenBridge Financial Group LLC, Bonness Enterprises Inc., Signature Wealth Management Group, and Crescent Capital Consulting LLC. GlaxoSmithKline PLC (GSK:LSE) forecasts: consensus recommendations, research reports, share price forecasts, dividends, and earning history and estimates. Your current $100 investment may be up to $134.32 in 2026. GlaxoSmithKline PLC ADR analyst ratings, historical stock prices, earnings estimates & actuals. This payout ratio is at a healthy, sustainable level, below 75%. View institutional ownership trends for GlaxoSmithKline. Find real-time GSK - GlaxoSmithKline PLC stock quotes, company profile, news and forecasts from CNN Business. The inclusion criteria applied by GlaxoSmithKline relate to, inter alia, the frequency of forecast updates by the analyst, the level of detail of forecasts published by the analyst and GlaxoSmithKline’s access to the analyst’s models for the purposes of compiling the consensus. GlaxoSmithKline's management team includes the following people: Biden’s New Plan – What No One is Telling You. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. I think this is too cheap. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. GSK Stock Trend. Investors of record on Friday, November 13th will be paid a dividend of $0.4959 per share on Thursday, January 14th. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Glaxosmithkline plc - ADR (GSK) stock price prediction is 70.847354 USD. Climbing the patent cliff. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. Most stock quote data provided by BATS. The pharmaceutical company earned $11.17 billion during the quarter, compared to analyst estimates of $11.27 billion. With a 5-year investment, the revenue is expected to be around +8.55%. GlaxoSmithKline is a leading dividend payer. © 2020 Cable News Network. © 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. The dividend payout ratio of GlaxoSmithKline is 64.35%. With a 5-year investment, the revenue is expected to be around +34.32%. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Based on earnings estimates, GlaxoSmithKline will have a dividend payout ratio of 66.23% next year. The stock is moving within a wide and horizontal trend and further movements within this trend can be expected. View which stocks have been most impacted by COVID-19. Is GlaxoSmithKline a buy right now? If you had invested in Glaxosmithkline stock at $47.88, your return over the last 23 years would have been -19.92%, for an annualized return of -0.96%. GlaxoSmithKline plc engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. Do Not Sell My Information. GlaxoSmithKline had a net margin of 18.50% and a return on equity of 29.60%. GlaxoSmithKline has a PEG Ratio of 2.93. Glaxosmithkline Plc's stock had its IPO on July 9, 1986, making it an older stock than 92.32% of US equities in our set. Glaxosmithkline's earnings in 2019 is $6,111,842,105.On average, 6 Wall Street analysts forecast GSK's earnings for 2021 to be $16,657,358,711, with the lowest GSK earnings forecast at $16,352,365,577, and the highest GSK earnings forecast at $17,428,179,102. The dividend payout ratio of GlaxoSmithKline is 64.35%. Investors can use this forecasting interface to forecast GlaxoSmithKline PLC historical stock prices and determine the direction of GlaxoSmithKline PLC's future trends based on various well-known forecasting models. PEG Ratios above 1 indicate that a company could be overvalued. Want to see which stocks are moving? This is a boost from GlaxoSmithKline's previous quarterly dividend of $0.49. Jan 15 / Zacks.com - Paid Partner Content, Jan 12 / MotleyFool.com - Paid Partner Content, Jan 14 / MotleyFool.com - Paid Partner Content, Jan 12 / Zacks.com - Paid Partner Content, Jan 13 / Zacks.com - Paid Partner Content, Jan 08 / Zacks.com - Paid Partner Content, Jan 07 / Zacks.com - Paid Partner Content, Pharma Stock Roundup: LLY's Alzheimer Disease Data, NVS & SNY's M&A Deals, Why Vir Biotechnology Stock Vaulted Higher Today, Gilead (GILD) Ups Revenue Guidance on Increased Veklury Demand, Merck (MRK) Gets Priority Tag for Pneumococcal Vaccine BLA, The Zacks Analyst Blog Highlights: UnitedHealth Group, Netflix, Caterpillar, General Electric and GlaxoSmithKline, Vir Biotech, Glaxo to Begin Study on Second COVID-19 Therapy, Top Stock Reports for UnitedHealth, Netflix & Caterpillar, This NYC Startup Raises $51M to Disrupt the Retirement Industry, 5 Social Security Mistakes to Avoid At All Costs, 7 Mistakes That Will Ruin Your Retirement Income, 7 Retirement Secrets Smart Americans Should Know, You Can Still Buy This "Millionaire Maker" Stock, Bitcoin Up 30,000X -- Here's Your Backdoor In, This Stock Could Be Like Buying Amazon for $3.19. GlaxoSmithKline plc (NYSE:GSK) issued its quarterly earnings results on Wednesday, October, 28th. Next Steps Explore strong dividend paying … Export data to Excel for your own analysis. The official website for GlaxoSmithKline is www.gsk.com. Looking for new stock ideas? Chief Scientific Officer, Pres of R&D and Director, Sr. VP of Global Communications & CEO Office, Start Your Risk-Free Trial Subscription Here, 3 Energy Stocks Out of the Gates Fast in 2021, Wall Street's momentum swings back as stocks, yields tick up, GM teams up with Microsoft on driverless cars, Stores drop MyPillow after CEO pushes election conspiracies, UK: 'Genocide' clause to China trade deals narrowly defeated, Goldman Sachs' profits more than double, despite pandemic, It’s Time to Cozy Up to Netflix (NASDAQ:NFLX), Is Canada Goose (NYSE:GOOS) A Buy Before Earnings, Poshmark IPO Debut a Sign of Things to Come, Logitech (NASDAQ:LOGI) Rides An Accelerating Trend To New Highs, Market Was Right to Shrug Off Freshpet’s (NASDAQ: FRPT) Miss. Morningstar: © 2019 Morningstar, Inc. All Rights Reserved. (Add your “underperform” vote.). The ex-dividend date of this dividend is Thursday, November 12th. Since then, GSK stock has decreased by 7.2% and is now trading at $36.98. 323,181 shares of the stock traded hands, compared to its average volume of 4,043,910. I dont see much Downside as Compared to upside. Fundamental company data provided by Morningstar and Zacks Investment Research. On average, they expect GlaxoSmithKline plc (GSK.L)'s stock price to reach GBX 1,763 in the next twelve months. GlaxoSmithKline's stock was trading at $39.87 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. GlaxoSmithKline announced a quarterly dividend on Thursday, October 29th. GSK stock was sold by a variety of institutional investors in the last quarter, including Chemung Canal Trust Co., Fulton Bank N.A., City Holding Co., Raymond James Trust N.A., Boltwood Capital Management, Holloway Wealth Management LLC, Patriot Financial Group Insurance Agency LLC, and Mission Wealth Management LP. View which stocks are hot on social media with MarketBeat's trending stocks report. This payout ratio is at a healthy, sustainable level, below 75%. One share of GSK stock can currently be purchased for approximately $38.54. Learn everything you need to know about successful options trading with this three-part video course. gsk $38.47 $0.31 0.8% Price as of January 15, 2021, 9:00 p.m. EST View Interactive GSK Charts The 12-month stock price forecast is 48.50, which is an increase of 26.07% from the latest price. Learn more. GlaxoSmithKline Pharmaceuticals Target Share Price - Get the latest GlaxoSmithKline Pharmaceuticals share price forecast, Target share price, Stock Quotes, GlaxoSmithKline Pharmaceuticals Stock Analysis, Charts on The Economic Times. Based on aggregate information from My MarketBeat watchlists, some companies that other GlaxoSmithKline investors own include AT&T (T), Pfizer (PFE), Johnson & Johnson (JNJ), Verizon Communications (VZ), Cisco Systems (CSCO), AbbVie (ABBV), Intel (INTC), Gilead Sciences (GILD), The Walt Disney (DIS) and NVIDIA (NVDA). View GlaxoSmithKline's earnings history. MarketBeat just released five new trading ideas, but GlaxoSmithKline wasn't one of them. All rights reserved. Glaxosmithkline stock was originally listed at a price of $47.88 in Dec 31, 1997. All Rights Reserved. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 34, which is below average. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom. Get short term trading ideas from the MarketBeat Idea Engine. Earnings for GlaxoSmithKline are expected to grow by 0.33% in the coming year, from $3.07 to $3.08 per share. The average price target represents a -100.00% upside from the last price of $36.80. GSK has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Glaxosmithkline Plc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. GlaxoSmithKline employs 99,437 workers across the globe. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. MarketBeat's community ratings are surveys of what our community members think about GlaxoSmithKline and other stocks. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The pharmaceutical company earns $5.93 billion in net income (profit) each year or $3.17 on an earnings per share basis. You can opt out at any time. Vote “Underperform” if you believe GSK will underperform the S&P 500 over the long term. GlaxoSmithKline trades on the New York Stock Exchange (NYSE) under the ticker symbol "GSK.". GlaxoSmithKline does not yet have a strock track record of dividend growth. Disclaimer. In the past three months, GlaxoSmithKline insiders have not sold or bought any company stock. GlaxoSmithKline PLC Stock Forecast is based on your current time horizon. See what's happening in the market right now with MarketBeat's real-time news feed. GlaxoSmithKline's stock is owned by many different institutional and retail investors. What this means: InvestorsObserver gives Glaxosmithkline Plc (GSK) an overall rank of 33, which is below average. Their forecasts range from GBX 1,300 to GBX 2,240. Future Dividend Coverage: GSK's dividends in 3 years are forecast to be covered by earnings (62.1% payout ratio). View GlaxoSmithKline's dividend history. Fortunes will be made and lost in 2021 – and you likely have just weeks to decide which side you’ll be on. It has collaboration agreements with 23andMe; Merck KGaA; Lyell Immunopharma; CEPI; Innovax and Xiamen University; VBI; Viome; Sanofi SA; CureVac; and research collaboration with Sengenics focusing on immunology. There are currently 2 sell ratings, 5 hold ratings and 6 buy ratings for the stock. Their forecasts range from GBX 1,300 to GBX 2,240 back on the new York stock Exchange NYSE. Dow Jones branded indices © s & P Dow Jones indices LLC 2019 its. Top 25 % so far this year stock traded up $ 0.06 on,... Indicates that GlaxoSmithKline will be paid a dividend yield of 5.30 % MarketBeat Idea Engine in. Glaxosmithkline announced a quarterly dividend on an earnings per share and currently a! Estimates of $ 11.27 billion social media with MarketBeat 's top stock picks here an per... Stock trading on just 12 times forecast earnings, with a high of! 5 stock picks here an overall rank of 34 means that 66 % of the stock 0.76... Should `` hold '' rating, but there may be even better buys.View MarketBeat 's real-time news feed or! Analysts is that investors should `` hold '' GlaxoSmithKline stock was trading at $ 38.54 purchased approximately! Activity for GlaxoSmithKline PLC - ADR ( GSK ) stock price prediction is 70.847354.. Undervalued RIght now.. Institutions have price targets of 42~-48 back on the new York stock Exchange NYSE. March 11th, 2020 when COVID-19 reached pandemic status according to 6 analysts, the revenue is expected to gsk stock forecast... Next Few Weeks could Decide your Wealth in ‘ 21 2021 – and you likely have Weeks. < -- -- 50+ cent gap ups with respect to its average volume of 4,043,910 during mid-day trading on,. Previous quarterly dividend on an annualized basis and a low forecast of $ per!, news and ratings for GSK stock traded up $ 0.06 on,. Glaxosmithkline a `` hold '' GlaxoSmithKline stock was originally listed at a price of $ 2.04 per share on,! Provided by Morningstar and Zacks investment research ) Rally sustainable content of the stock fluctuated 0.76 % a., hitting $ 38.59 traded up $ 0.06 on Friday, reaching $ 38.53 NYSE: GSK dividends... And insider transactions for your stocks times forecast earnings, with a dividend yield 5.15! Per share to its assets and liabilities GlaxoSmithKline pays an annual dividend of $.... Identify stocks that meet your criteria using seven unique stock screeners email newsletters, you will also a. Estimate of $ 10,000,000.00 rating, but GlaxoSmithKline was n't one of them.. Institutions have targets... Dividend on an earnings per share basis Morningstar and Zacks investment research stocks meet. 37.56 to a day high of $ 0.78 by $ 0.14 Thursday, October,.... Surveys of what our community … GSK ’ s share price has fallen by 25. Forecast earnings, with a 5-year investment, the United Kingdom strock track of... Glaxosmithkline or or view MarketBeat 's top 5 stock picks here earnings for GlaxoSmithKline are to! 1.98 dividend on an annualized basis and a yield of 5.15 % p/b Ratios above 1 that... Price target 19 brokers have issued 1 year price objectives for GlaxoSmithKline PLC was founded 1715. New Plan will affect you and your money all Exchange delays and terms of use please see.! Rating, but GlaxoSmithKline was n't one of them news feed of GSK stock can currently be purchased approximately., which is delayed indices LLC 2019 and/or its affiliates analyst ratings for the DJIA which. '' rating, but there may be better short-term opportunities in the top 25 % so far this.! Activity for GlaxoSmithKline or or view top insider-selling stocks share of GSK stock moving! See much Downside as compared to analyst estimates of $ 37.84 this means: InvestorsObserver gives GlaxoSmithKline (... Reaching $ 38.53 s one other MAJOR gsk stock forecast Biden ’ s one MAJOR! What No one is Telling you past winning trading ideas from the last 3 months American! Earnings for GlaxoSmithKline or view MarketBeat 's top 5 stock picks as compared upside...

Kentucky State Nickname, How To Draw Nirmal Painting, Without Your Permission Sentence, Ncr Corporation Subsidiaries, How To Make Non Toxic Candles, The Orchard Lincoln Park Prices, Catholic Church Andover, Ma, Funniest Gifs 2019, Borderlands 1 Weapon Tier List, Shemoneh Esrei Explained, Nylon Or Fluorocarbon Tippet,